Elizabeth Roper Ph.D.
Liz has more than 22 years of experience in the life science and healthcare industry, either as a venture investor or an operating executive. She has held senior operation roles and held various directorships including Chair. She focuses on shaping and building early stage life science opportunities into successful companies and investments.
Prior to joining Epidarex, Liz was Head of Business Development and part of the management team at Chroma Therapeutics Ltd., an Oxford-based venture-backed drug discovery and development company focused on inflammatory disorders and oncology. Liz led the establishment of several major company-building alliances including a multi‐target deal with GlaxoSmithKline around Chroma’s novel platform.
Liz is a former executive with the life science venture capital team at the Investments Division of The Wellcome Trust. She is also a former member of the life Science team at Atlas Ventures, London.
Liz currently serves on the Board of Directors of AdoRx Ltd. (Chair), Nodthera Ltd., Mironid Ltd., Caldan Therapeutics Ltd., Exeed Ltd. (Chair), EM Imaging Ltd, Macomics Ltd. and Dunad Ltd.
Liz holds a B.Sc. (Hons) in Biochemistry (1st class) from the University College Cork, and a Ph.D. from the Imperial Cancer Research Fund.